Sarepta Therapeutics, Inc.Sarepta Therapeutics, Inc.Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

No trades
See on Supercharts

Price target

191.950.000.00%
The 19 analysts offering 1 year price forecasts for SRPT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 21 analysts giving stock ratings to SRPT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SRPT EPS for the last quarter is 0.34 USD despite the estimation of −0.06 USD. In the next quarter EPS is expected to reach 1.56 USD. Track more of Sarepta Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Sarepta Therapeutics, Inc. revenue is expected to reach ‪589.42 M‬ USD. Check out Sarepta Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SRPT price target is 191.95 USD with a max estimate of 219.00 USD and a min estimate of 150.00 USD. Check if this forecast comes true in a year, meanwhile watch Sarepta Therapeutics, Inc. stock price chart and keep track of the current situation with SRPT news and stock market news.
We've gathered opinions of 21 analysts rating SRPT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.